NCT07330362

Brief Summary

This research project aims to collect images from patients with chronic glomerulonephritis. For each subject, the images obtained from renal biopsy will undergo evaluation by both the diagnostic model and the 'gold standard' diagnosis by pathologists. The researchers will test the subjects using the diagnostic model and compare the results with the known 'gold standard' diagnosis, in order to evaluate the AUC, specificity, and sensitivity of the diagnostic model.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,900

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Jul 2024

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jul 2024Dec 2026

Study Start

First participant enrolled

July 1, 2024

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

December 28, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

January 27, 2026

Status Verified

December 1, 2025

Enrollment Period

2.5 years

First QC Date

December 28, 2025

Last Update Submit

January 25, 2026

Conditions

Keywords

Artificial intelligenceTEM-AIDglomerulonephritis

Outcome Measures

Primary Outcomes (1)

  • The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of the TEM-AID artificial intelligence model

    The area under curve (AUC) of Receiver Operating Characteristic (ROC) curves of the TEM-AID artificial intelligence model for candidates will be calculated.

    baseline

Secondary Outcomes (2)

  • The specificity of the TEM-AID artificial intelligence model.

    baseline

  • The sensitivity of the TEM-AID artificial intelligence model.

    baseline

Eligibility Criteria

Age15 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

For patients with chronic kidney disease who need further diagnosis through renal biopsy.

You may qualify if:

  • Voluntary signing of informed consent form;
  • Patients clinically diagnosed or suspected of having chronic kidney disease according to the 2023 KDIGO Clinical Practice Guideline for the Evaluation and Management of Kidney Disease;
  • Undergoing renal biopsy and pathological specimen preparation.

You may not qualify if:

  • Biopsy tissue from donor kidney or transplanted kidney;
  • Poor quality of pathological specimen, unable to conduct pathological diagnosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Nanfang Hospital

Guangzhou, Guangdong, China

RECRUITING

Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, China

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, ChronicGlomerulonephritis

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsNephritis

Central Study Contacts

Yangshu Zhou

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 28, 2025

First Posted

January 9, 2026

Study Start

July 1, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

January 27, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations